Efficient elimination of primary B-ALL cells in vitro and in vivo using a novel 4-1BB-based CAR targeting a membrane-distal CD22 epitope.
Velasco-Hernandez T, Zanetti SR, Roca-Ho H, Gutierrez-Aguera F, Petazzi P, Sánchez-Martínez D, Molina O, Baroni ML, Fuster JL, Ballerini P, Bueno C, Fernandez-Fuentes N, Engel P, Menendez P.
Velasco-Hernandez T, et al.
J Immunother Cancer. 2020 Aug;8(2):e000896. doi: 10.1136/jitc-2020-000896.
J Immunother Cancer. 2020.
PMID: 32788237
Free PMC article.